Long-term survival in a patient with chronic myelogenous leukemia without any treatment

authors:

avatar A Shahriari 1 , * , avatar HR Emaami 1

Iran

how to cite: Shahriari A, Emaami H. Long-term survival in a patient with chronic myelogenous leukemia without any treatment. J Kermanshah Univ Med Sci. 2002;6(2):e81011.

Abstract

Chronic myelogenous leukemia (CML) is a myeloproliferative disease with a well known course. With chemotherapy,   average survival of these  patients is   3-5 years. All of the   long term survivors  of CML   have been  treated patients. Here we are reporting on a  long term survivor (more than 10 years)  without treatment.

Fulltext

The full text of this article is available on PDF

© 2002, Journal of Kermanshah University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.